Your browser doesn't support javascript.
loading
F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injury.
Gupta, Shruti; Green-Lingren, Olivia; Bhimaniya, Sudhir; Krokhmal, Aleksandra; Jacene, Heather; Ostermann, Marlies; Chicklore, Sugama; Sprangers, Ben; Deroose, Christophe M; Herrmann, Sandra M; Wells, Sophia L; Kaunfer, Sarah A; Ortega, Jessica L; García-Carro, Clara; Bold, Michael; Chen, Kevin L; Sise, Meghan E; Heidari, Pedram; Pak, Wai Lun Will; Lee, Meghan D; Beckerman, Pazit; Eshet, Yael; Hsu, Raymond K; Hernandez Pampaloni, Miguel; Rashidi, Arash; Avril, Norbert; Donley, Vicki; Mithani, Zain; Kuker, Russ; Awiwi, Muhammad O; Wang, Mindy X; Shah, Sujal I; Weintraub, Michael D; Schoder, Heiko; Chowdhury, Raad B; Seethapathy, Harish; Reynolds, Kerry L; Soler, Maria Jose; Abudayyeh, Ala; Glezerman, Ilya; Leaf, David E.
Afiliação
  • Gupta S; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Green-Lingren O; Adult Survivorship Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Bhimaniya S; Harvard Medical School, Boston, Massachusetts, USA.
  • Krokhmal A; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Jacene H; Harvard Medical School, Boston, Massachusetts, USA.
  • Ostermann M; Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Chicklore S; Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Sprangers B; Harvard Medical School, Boston, Massachusetts, USA.
  • Deroose CM; Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Herrmann SM; Department of Critical Care & Nephrology, King's College London, Guy's and St. Thomas' Hospital, London, United Kingdom.
  • Wells SL; King's College London & Guy's and St. Thomas' PET Centre, London, United Kingdom.
  • Kaunfer SA; Biomedical Research Institute, Department of Immunology and Infection, UHasselt, Diepenbeek, Belgium.
  • Ortega JL; Department of Nephrology, Ziekenhuis Oost Limburg, Genk, Belgium.
  • García-Carro C; Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium.
  • Bold M; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
  • Chen KL; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Sise ME; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Heidari P; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Pak WLW; Nephrology Department, San Carlos Clinical University Hospital, Madrid, Spain.
  • Lee MD; Department of Radiology, Division of Nuclear Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Beckerman P; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Eshet Y; Harvard Medical School, Boston, Massachusetts, USA.
  • Hsu RK; Department of Medicine, Division of Nephrology, and.
  • Hernandez Pampaloni M; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Rashidi A; Renal Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York, USA.
  • Avril N; Department of Medicine, Division of Nephrology, and.
  • Donley V; Institute of Nephrology and Hypertension, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Tel Aviv, Israel.
  • Mithani Z; Department of Nuclear Imaging, Chaim Sheba Medical Center, Ramat Gan, Israel.
  • Kuker R; Division of Nephrology and.
  • Awiwi MO; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.
  • Wang MX; Division of Nephrology and Hypertension, University Hospital Cleveland Medical Center, Cleveland, Ohio, USA.
  • Shah SI; Department of Radiology, Nuclear Medicine, University Hospitals, Cleveland, Ohio, USA.
  • Weintraub MD; Division of Nephrology and Hypertension, University Hospital Cleveland Medical Center, Cleveland, Ohio, USA.
  • Schoder H; Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Chowdhury RB; Department of Radiology, Division of Nuclear Medicine, University of Miami, Miami, Florida, USA.
  • Seethapathy H; Division of Diagnostic Imaging, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Reynolds KL; Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Soler MJ; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Abudayyeh A; Harvard Medical School, Boston, Massachusetts, USA.
  • Glezerman I; Department of Radiology, Division of Abdominal Imaging and Intervention, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Leaf DE; Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
J Clin Invest ; 134(18)2024 Aug 08.
Article em En | MEDLINE | ID: mdl-39115940
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fluordesoxiglucose F18 / Tomografia por Emissão de Pósitrons / Injúria Renal Aguda / Inibidores de Checkpoint Imunológico Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Invest Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fluordesoxiglucose F18 / Tomografia por Emissão de Pósitrons / Injúria Renal Aguda / Inibidores de Checkpoint Imunológico Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Invest Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos